Short Communication | Open Access
Y. Kenan Coban, Murat Aral, "Serum IL-18 Is Increased at Early Postburn Period in Moderately Burned Patients", Mediators of Inflammation, vol. 2006, Article ID 016492, 4 pages, 2006. https://doi.org/10.1155/MI/2006/16492
Serum IL-18 Is Increased at Early Postburn Period in Moderately Burned Patients
A severe systemic inflammatory response is usually seen after burn injury. IL- enhances the Th1 immune responses in bacterial andviral infections. In order to evaluate the IL- serum levels as well as IL- and TNF- at the th hour postburn, serial serum samples of burned patients were analyzed. moderately burned patients were included into the study. Serum samples were taken at admission at the th hour of postburn. IL-, IL-, and TNF- serum levels were analyzed. Total mean burned surface area (TBSA) was and mean BMI (body mass index) was . The patients' age ranged from to (mean ) years. An increase in sera IL-, IL-, and TNF- was detected at the th hour postburn (). All patients survived. A marked increase in serum levels of IL- as well as the other cytokines evaluated was observed in the moderately burned patients. These three parameters were highly correlated with each other ( and ). This is the first study that shows an increase in serum IL- levels at the early postburn period.
- M Ueyama, I Maruyama, M Osame, and Y Sawada, “Marked increase in plasma interleukin-6 in burn patients,” The Journal of Laboratory and Clinical Medicine, vol. 120, no. 5, pp. 693–698, 1992.
- S Endo, K Inada, Y Yamada et al., “Plasma tumour necrosis factor- (TNF-) levels in patients with burns,” Burns, vol. 19, no. 2, pp. 124–127, 1993.
- A L Dugan, W B Malarkey, S Schwemberger, E C Jauch, C K Ogle, and N D Horseman, “Serum levels of prolactin, growth hormone, and cortisol in burn patients: correlations with severity of burn, serum cytokine levels, and fatality,” Journal of Burn Care & Rehabilitation, vol. 25, no. 3, pp. 306–313, 2004.
- J P de Bandt, S Chollet-Martin, A Hernvann et al., “Cytokine response to burn injury: relationship with protein metabolism,” The Journal of Trauma, vol. 36, no. 5, pp. 624–628, 1994.
- F L Yeh, W L Lin, and H D Shen, “Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients,” Burns, vol. 26, no. 5, pp. 454–459, 2000.
- F L Yeh, W L Lin, H D Shen, and R H Fang, “Changes in circulating levels of interleukin 6 in burned patients,” Burns, vol. 25, no. 2, pp. 131–136, 1999.
- F L Yeh, W L Lin, H D Shen, and R H Fang, “Changes in serum tumour necrosis factor- in burned patients,” Burns, vol. 23, no. 1, pp. 6–10, 1997.
- D Takeuchi, H Yoshidome, A Kato et al., “Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice,” Hepatology, vol. 39, no. 3, pp. 699–710, 2004.
- F N Lauw, J Branger, S Florquin et al., “IL-18 improves the early antimicrobial host response to pneumococcal pneumonia,” The Journal of Immunology, vol. 168, no. 1, pp. 372–378, 2002.
- “American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Critical Care Medicine, vol. 20, no. 6, pp. 864–874, 1992.
- K Nakanishi, T Yoshimoto, H Tsutsui, and H Okamura, “Interleukin-18 regulates both Th1 and Th2 responses,” Annual Review of Immunology, vol. 19, pp. 423–474, 2001.
- K Nakanishi, T Yoshimoto, H Tsutsui, and H Okamura, “Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu,” Cytokine & Growth Factor Reviews, vol. 12, no. 1, pp. 53–72, 2001.
- H Okamura, H Tsutsi, T Komatsu et al., “Cloning of a new cytokine that induces IFN- production by T cells,” Nature, vol. 378, no. 6552, pp. 88–91, 1995.
- S Ushio, M Namba, T Okura et al., “Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein,” The Journal of Immunology, vol. 156, no. 11, pp. 4274–4279, 1996.
- A Billiau, “Interferon-gamma: biology and role in pathogenesis,” Advances in Immunology, vol. 62, pp. 61–130, 1996.
- W-D Döcke, F Randow, U Syrbe et al., “Monocyte deactivation in septic patients: restoration by IFN- treatment,” Nature Medicine, vol. 3, no. 6, pp. 678–681, 1997.
- B Conti, J W Jahng, C Tinti, J H Son, and T H Joh, “Induction of interferon- inducing factor in the adrenal cortex,” The Journal of Biological Chemistry, vol. 272, no. 4, pp. 2035–2037, 1997.
- T Suda, T Takahashi, P Golstein, and S Nagata, “Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family,” Cell, vol. 75, no. 6, pp. 1169–1178, 1993.
- A McKay, M Komai-Koma, K J MacLeod et al., “Interleukin-18 levels in induced sputum are reduced in asthmatic and normal smokers,” Clinical & Experimental Allergy, vol. 34, no. 6, pp. 904–910, 2004.
- F Giugliano, K Esposito, C Di Palo et al., “Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men,” Journal of Endocrinological Investigation, vol. 27, no. 7, pp. 665–669, 2004.
- H M Wang, W F Cao, Y Z Peng, G X Xiao, and X Y Yang, “Changes in plasma levels of LPS, TNF- and IL-6 in burn patients with severe infection treated with Imipenem or Cefoperazone,” Zhonghua Shao Shang Za Zhi, vol. 20, no. 2, pp. 95–97, 2004 (Chinese).
- M Kinoshita, S Seki, S Ono, N Shinomiya, and H Hiraide, “Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice,” Annals of Surgery, vol. 240, no. 2, pp. 313–320, 2004.
- M G Netea, G Fantuzzi, B J Kullberg et al., “Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia,” The Journal of Immunology, vol. 164, no. 5, pp. 2644–2649, 2000.
- B Liu, I Mori, M J Hossain, L Dong, K Takeda, and Y Kimura, “Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity,” Journal of General Virology, vol. 85, no. pt 2, pp. 423–428, 2004.
- K Kohno, J Kataoka, T Ohtsuki et al., “IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12,” The Journal of Immunology, vol. 158, no. 4, pp. 1541–1550, 1997.
Copyright © 2006 Y. Kenan Coban and Murat Aral. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.